Detection of familial cancer risk in Indian men with prostate cancer.
Not Applicable
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2021/01/030180
- Lead Sponsor
- AIIMS Intramural Fund
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Histo-pathologically proven case of adeno-carcinoma prostate with either regional (node-positive) or metastatic disease.
Exclusion Criteria
Patients will be excluded from this study if:
1. he has physical, cognitive or psychiatric conditions that interfere with the ability to give informed consent;
2. he is less than 18 years of age.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of pathogenic or likely pathogenic(p/LP) germline mutations in the cohort.Timepoint: 2 years
- Secondary Outcome Measures
Name Time Method Correlation of pathogenic or likely pathogenic mutations with Clinical features, Gleason-scores and family historyTimepoint: 2 years